Article
Molecular Foundations for Personalized Therapy in Prostate Cancer
9 Feb 2015
Abstract excerpt
Prostate cancer is the most common and second most lethal cancer in men. The majority of prostate cancers are histologically similar to acinar adenocarcinomas and rely on androgen-dependent signaling for their development and progression. Androgen deprivation therapy is a mainstay of treatment regimens and we discuss the recent advancements in androgen-deprivation therapy. Recent advances in defining the genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
